News for ORGANON & CO (OGN.MX)

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Organon & Co.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Organon & Co. (NYSE:OGN) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - CEOJuan...

The following slide deck was published by Organon & Co.

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. ”œIn 2024 we achieved our third year of consta

Organon & Co. (NYSE:OGN) JPMorgan Annual Healthcare Conference Call January 13, 2025 6:45 PM ETCompany ParticipantsKevin Ali - Chief Executive...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Organon & Co.

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.

Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look at where Organon & Co.

Investing in healthcare stocks during lean economic times is generally regarded as defensive.

SAN MATEO, Calif. —

Roth analysis: Has volatility created a trigger warning for stocks?

Kenvue stock has not participated in the recent rotation into value stocks. It trades at a forward P/E of 16 and a free cash flow yield of 6%.

iShares S&P Small-Cap 600 Value ETF has a sizable asset base of more than $6.8 billion at a relatively low expense ratio of just 0.18%. Read more on IJS here.

Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024